Effect of angiotensin-converting-enzyme inhibitors.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology*; D002478:Cells, Cultured; D004357:Drug Synergism; D006801:Humans; D015260:Neprilysin / Q000037:antagonists & inhibitors; D011725:Pyridines / Q000494:pharmacology*; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin / Q000187:drug effects*; D013841:Thiazepines / Q000494:pharmacology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D011725:Pyridines; D043782:Receptor, Bradykinin B2; D018002:Receptors, Bradykinin; D013841:Thiazepines; C106266:omapatrilat; D015260:Neprilysin; D001920:Bradykinin